Диссертация (1139521), страница 48
Текст из файла (страница 48)
Intestinal hypoxia-inducible factor-2ci (HIF-2 α) is critical forefficient erythropoiesis / E. Anderson, X. Xue, Y. Shah // J. Biol. Chem. – 2011. – Vol.286, Iss. 22. – P. 19533–19540.475. Antibodies to S100 Protein in Anxiety-Depressive Disorders in Experimental and Clinical Conditions / T. A.
Voronina [et al.] // Animal Models in BiologicalPsychiatry / ed. A. V. Kalueff. – New York: Nova Scienxt Publishers, 2006. – Chapter8. – P. 137–152.476. Antibodies to S100 proteins have anxiolytic-like activity at ultra-low dosesin the adult rat / V. Castagné [et al.] // J. Pharm. Pharmacol. – 2008. – Vol. 60, Iss. 3. –P.
309–316.477. Antioxidants in translational medicine / H. Schmid [et al.] // Antioxid. Redox Signal. – 2015. – Vol. 23, Iss. 14. –P. 1130–1143.478. Apolipoprotein-defined and NMR lipoprotein subclasses in the veterans affairs diabetes trial / M. Azar [et al.] // J. Diabet. Complicat. – 2013. – Vol. 27, Iss. 6. –P. 627–632.293479. Ashraf, M. Z. Scavenger receptors: implication atherothrombotic disorders /M. Z. Ashraf, N. Gupta // Int. J. Biochem. Cell Biol. – 2011. – Vol. 43, Iss.
5. – P. 697–700.480. Atochin, D. N. Endothelial nitric oxide synthase transgenic models of endothelial dysfunction / D. N. Atochin, P. L. Huang // Pflugers Arch. – 2010. – Vol. 460,Iss. 6. – P. 965–974.481. Avery, S. V. Molecular targets of oxidative stress // Biochem. J. – 2011. –Vol. 434, Iss. 2. – P. 201–210.482. Balakumar, P.
Classical and pleiotropic actions of dipyridamole: Notenough light toilluminate the dark tunnel? / P. Balakumar, Y. Nyoa, R. Renushiaa //Pharmacol. Res. – 2014. – Vol. 87. – P. 144-150.483. Banks, W. A. The blood-brain and immune function and disfunction /W. A. Banks, M. A.
Erickson // Neurobiol. Dis. – 2010. – Vol. 37, Iss. 1. – P. 26–32.484. Banwell, V. Systematic review and stratified meta-analysis of the efficacy ofinterleukin-1 receptor antagonist in animal models of stroke / V. Banwell, E. S. Sena,M. R. Macleod // J. Stroke Cerebrovasc. Dis. – 2009. – Vol. 18, Iss. 4. – P. 269–276.485. Barrondo, S. Allosteric modulation of 5-HT(lA] receptors by zinc: bindingstudies / S. Barrondo, J. Salles // Neuropharmacology. – 2009. – Vol.
56. – P. 455–462.486. Barzegar, A. Proton-Coupled Electron-Transfer Mechanism for the RadicalScavengingActivity of Cardiovascular Drug Dipyridamole // PLoS ONE. – 2012. – Vol.7, Iss. 6. – P. 39660.487. Bauer, V. Nitric oxide—the endothelium-derived relaxing factor and its rolein endothelial functions / V. Bauer, R. Sotnikova // Gen. Physiol. Biophys. – 2010. –Vol. 29, Iss. 4. – P. 319–340.488. BDNF and epilepsy too much of a good thing / K. Devin [et al.] // TrendsNeurosci. – 2001. – Vol.
24, Iss. 1. – P. 47–53.489. Benarroch, E. Neurovascular unit dysfunction: a vascular component ofAlzheimer disease? // Neurology. – 2007. – Vol. 68, Iss. 20. – P. 1730–1732.490. Bettermann, K. Biomarkers for stroke: in search of fingerprints // J. StrokeCerebrovase Dis. – 2011. – Vol. 20, Iss. 3. – P. 173–176.294491. Biobel, B. Translational medicine meets new technologies for enabling personalized cfre // Stud Health Technol inform. – 2013. – Vol.
189. – P. 8–231.492. Bone marrow N R4A expression is not a dominant factor in the developmentof atherosclerosis or macrophage polarization in mice / L. C. Chao [et al.] // J. Lipid.Res. – 2013. – Vol. 54, Iss. 3. – P. 806–815.493. Bone morphogenetic protein-6 reduces ischemia-induced brain damage inrats / Y. Wang [et al.] // Stroke. – 2001. – Vol. 32, Iss.
9. – P. 2170–2178.494. Bulter, G. S. Updated biological roles for matrix metalloproteinases and new«intracellular» substrates revealed degradomics / G. S. Bulter, C. M. Overal // Biochemistry. – 2009. – Vol. 48, Iss. 46. – P. 10830–10845.495. Buzsaki, G. Inhibition and brain work / G. Buzsaki, K. Kaila, R. Raichle //Neuron. – 2007. – Vol. 56, Iss. 5. – P. 771–783.496. CDP- choline significantly restores phosphatidylcholine levels by differentially affecting Phospholipase A2 and CTP: phosphocholine cytidylyltransferase afterStroke / R. M. Adibhatla [et al.] // J. Biol. Chem. – 2006. – Vol. 281, Iss. 10.
– P. 6718–6725.497. CDP-choline treatment induces brain plasticity markers expression in experimental animal stroke / M. Gutiérrez-Fernández [et al.] // Neurochem. Int. – 2012. –Vol. 60, Iss. 3. – P. 310–317.498. Cell signaling by protein carbonylation and decarbonylation / C. M. Wаng[et al.] // Antioxid. Redox Signal. – 2010. – Vol. 12, Iss. 3. – P. 393–404.499. Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders / V. Calabrese [et al.] //Antioxid. Redox Signal.
– 2010. – Vol. 13, Iss. 11. – P. 1763–1811.500. Cemloplasmin/Transferrin system is related to clinical status in acute stroke/ C. Altamura [et al.] // Stroke. – 2009. – Vol. 40, Iss. 4. – P. 1282–1288.501. Central nervous system involvement in patients with HCV-related cryoglobulinemia; literature review and a case report / D. Filippini [et al.] // Reumatismo. –2002. – Vol. 54, Iss. 2. – P. 150–155.295502.
Cerebral microbleeds: a field guide to the detection and interpretation /S. M. Greenberg [et al.] // Lancet Neurology. – 2009. – Vol. 8, No 2. – P. 1654–1674.503. Chabriat, H. Vascular dementia: potential of antiplatelet agents in prevention/ H. Chabriat, M.
G. Bousser // Eur. Neurol. – 2006. – Vol. 55, Iss. 2. – P. 61–69.504. Chillon, J. M. Autoregulation:arterial and intracranial pressure /J. M. Chillon, G. L. Baumbach // Cerebral Blood Flow and Metabolism / eds.:L. Edvinsson, D. N. Krause. – Philadelphia : Li ppincot Williams & Wilkins, 2002. –P. 395–412.505. Cholinesterase inhibitors for patients with Alzheimer's disease: systematicreview of randomized clinical trials / H. Kaduszkiewicz [et al.] // BMJ. – 2005.
– Vol.331, Iss. 7512. – P. 321–327.506. Chowdhary, S. Nitric oxide and hypertension: not just an endothelium derived relaxing factor! / S. Chowdhary, J. N. Townend // J. Hum. Hypertens. – 2001. –Vol. 15, Iss. 4. – P. 219–227.507. Chrysant, S. G. Possible pathophysiologic mechanisms supporting the superior stroke protection of angiotensin receptor blockers compared to angiotesinconverting enzyme inhibitors: clinical and experimental evidence // J. Human Hypertension.
– 2005. – Vol. 19, Iss. 12. – P. 923–931.508. Citicoline treatment prevents neurocognitive decline after a first ischemicstroke (Poster 743) / J. Alvarez-Sabin [et al.] // Cerebrovasc. Dis. – 2010. – Vol. 29,suppl, 2. – C. 268.509. Citicoline, use in cognitive decline: vascular and degenerative / R. GarciaCobos [et al.] // J. Neurol. Sci.
– 2010. – Vol. 299, Iss. 1-2. – P. 188–192.510. Cognitive outcomes of preterm inflants randomized to darbepoetin, erythropoietin, or placebo / R. K. Ohls [et al.] // Pediatrics. – 2014. – Vol. 133, Iss. 6. – P.1023–1030.511. Cohen, J. E. Acute middle cerebral artery occlusion: reappraisal of the roleof endovascular revascularization // Int. J.
Stroke. – 2013. – Vol. 8, Iss. 2. – P. 109–110.512. Cole, D. S. Beyond lysis: how complement influences cell fate / D. S. Cole,В. P. Morgan // Clin. Sci. – 2003. – Vol. 104, Iss. 5. – P. 455–466.296513. Complementation of mitochondrial electron transport chain by manipulationof the NAD+/NADH ratio / D. Titov [et al.] // Science. – 2016. – Vol. 352, N 6282. – P.231–235.514. Constrictor and Dilator Effects of Angoitensin II on Cerebral Arterioes / J.M. Vincent [et al.] // Stroke. – 2005. – Vol. 36, Iss. 12. – P.
2691–2695.515. C-reactive protein as a predictor of adverse outcome in patients with acutecoronary syndrome / A. S. Sheikh [et al.] // Heart Views. – 2012. – Vol. 13, Iss. 1. –P. 7–12.516. C-reactive protein concentration and risk of coronary heart disease, stroke,and mortality: an individual participant meta-analysis / S. Kaptoge [et al.] // Lancet. –2010. – Vol. 375, N 9709.
– P. 132–140.517. C-reactive protein is elevated in schizophrenia / F. Dickerson [et al.] //Schizophr. Res. – 2013. – Vol. 134, Iss. 1. – P. 198–202.518. C-reactive protein-mediated suppression of nephrotoxic nephritis: role ofmacrophages, complement, and Fey receptors / W. Rodriguez [et al.] // J. Immunol. –2007. – Vol. 178, Iss. 1. – P. 530–538.519. Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids / A.
L. Groeger [et al.] // Nat. Chem. Biol. – 2010. – Vol. 6, Iss. 10. – P. 433–441.520. Cytokines and chemokines in infectious diseases handbook / eds. M. Kotb,T. Calandra. – Totowa, New Jersey : Humana Press, 2010. – 456 p.521. Dabek, J. Nuclear factor kappa-light-chain-enhancer of activated b cells(NF-κB): A new potential therapeutic target in atherosclerosis? / J. Dabek, A. Kulach,Z. Gasior // Pharmacol. Rep.
– 2010. – Vol. 62, Iss. 5. – P. 778–783.522. Damage to neurons and oligodendrocytes in the hippocampal CA1 sector after transient focal ischemia in rats / H. Uchida [et al.] // Cell Mol. Neurobiol. – 2010. –Vol. 30, Iss. 7. – P. 1125–1134.523. Dávalos, A. Citicoline preclinical and clinical update 2009–2010 /A.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
